SETBP1 and acute myeloid leukemia: To determine if DC/DCleu-stimulated immunoreactive cells were further activated by the addition of LAA (AML) and SEB (healthy), we added LAA WT-1 and PRAME to uncultured WB and WB after MLC with and without Kit M treatment of AML samples and, in analogy, SEB to healthy samples.